Subscribe to RSS
DOI: 10.1055/a-1842-3641
Antibiotika in der parodontalen Therapie
![](https://www.thieme-connect.de/media/zahnmedizin-u2d/202203/lookinside/thumbnails/10-1055-a-1842-3641_zm_jepsen-1.jpg)
Aufgrund der Rolle von Bakterien in der Ätiopathogenese der Parodontitis kommen Antibiotika in der Parodontologie bereits seit mehreren Jahrzehnten zum Einsatz. Eine sorgfältige Nutzen-Risiko-Abwägung hinsichtlich möglicher Nebenwirkungen und insbesondere Resistenzbildungen spielt heute eine sehr wichtige Rolle bei der Indikationsstellung. Dieser Beitrag fasst den aktuellen Stand vor dem Hintergrund neuer Erkenntnisse und Empfehlungen zusammen.
-
Systemische Antibiotika sollen bei Parodontitispatienten nicht routinemäßig zusätzlich zur subgingivalen Instrumentierung eingesetzt werden.
-
In einer Nutzen-Risiken-Analyse überwiegen Bedenken hinsichtlich unerwünschter Nebenwirkungen für den Patienten und Förderung der Antibiotikaresistenzen in der Bevölkerung.
-
Die adjuvante Verwendung bestimmter Antibiotika (Metronidazol mit oder ohne Amoxicillin) in der Therapiestufe 2 kann für bestimmte Patientengruppen mit nachgewiesener rascher Progression (z. B. generalisierte Stadien III/IV der Parodontitis bei jungen Erwachsenen) erwogen werden.
-
Die Behandlung dieser speziellen Hochrisikopatienten sollte idealerweise von Spezialist*innen durchgeführt werden (DG PARO-Spezialist oder Fachzahnarzt für Parodontologie).
-
Die Indikation und die Beurteilung des Behandlungserfolgs orientieren sich am klinischen Bild und nicht am Ergebnis mikrobiologischer Diagnostik.
-
Eine systemische Antibiotikagabe bei Parodontitispatienten darf keineswegs Ersatz für eine unzureichende subgingivale Instrumentierung oder mangelhafte Mundhygiene sein.
-
Der Nutzen einer perioperativen Antibiotikaprophylaxe bei parodontalchirurgischen Eingriffen oder aber derjenige einer systemischen antibiotischen Begleittherapie bei regenerativ-chirurgischen Eingriffen ist nicht erwiesen.
-
Bestimmte lokal applizierte Antibiotika mit anhaltender Freisetzung können bei Parodontitispatienten zusätzlich zur subgingivalen Instrumentierung erwogen werden.
-
Ihr Einsatz ist nur bei Patienten mit wenigen lokalisierten tiefen Taschen und bei sehr guter Mundhygiene sinnvoll, da andernfalls eine rasche Reinfektion stattfindet.
-
Akute parodontale Zustände (Taschenabszesse mit Ausbreitungstendenz beziehungsweise ulzerierende Parodontalerkrankungen) können eine systemische Antibiotikagabe erforderlich machen.
Publication History
Article published online:
22 August 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Jepsen S, Dommisch H, Kebschull M. Ätiologie der Parodontitis: Gibt es neue Erkenntnisse?. zm 2018; 108: 66
- 2 Kilian M, Chapple IL, Hannig M. et al. The oral microbiome – an update for oral healthcare professionals. Br Dent 2016; 221: 657-666
- 3 Rupf S, Hannig M. Das humane Mikrobiom und seine Bedeutung für die Zahnmedizin. zm 2020; 110: 2292
- 4 Hagenfeld D, Prior K, Ehmke B. Das parodontalpathogene Mikrobiom bei Parodontitispatienten. zm 2021; 111: 42
- 5 Mombelli A. Antimicrobial Advances in treating periodontal Diseases. In: Kinane DF, Mombelli A. eds. Frontiers of oral Biology: periodontal Disease. Basel: Karger AG; 2012: 133-148
- 6 Wollkopf AD, Mutters NT. Antibiotikaresistenzen – die stille Pandemie. zm 2022; 112: 954
- 7 Cosgarea R, Wenzel S, Jepsen K. Systemische Antibiotika in der Parodontaltherapie: Nutzen und Risiken. zm 2022; 112: 36-41
- 8 Herrera D, Sanz M, Jepsen S. et al. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 2002; 29 (Suppl. 03) 136-159
- 9 Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 2003; 8: 115-181
- 10 Herrera D, Contreras A, Gamonal J. et al. Subgingival microbial profiles in chronic periodontitis patients from Chile, Colombia and Spain. J Clin Periodontol 2008; 35: 106-113
- 11 Sgolastra F, Petrucci A, Gatto R, Monaco A. Effectiveness of systemic amoxicillin/metronidazole as an adjunctive therapy to full-mouth scaling and root planing in the treatment of aggressive periodontitis: a systematic review and meta-analysis. J Periodontol 2012; 83: 731-743
- 12 Sgolastra F, Gatto R, Petrucci A. et al. Effectiveness of systemic amoxicillin/metronidazole as adjunctive therapy to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis. J Periodontol 2012; 83: 1257-1269
- 13 Keestra JA, Grosjean I, Coucke W. et al. Non-surgical periodontal therapy with systemic antibiotics in patients with untreated chronic periodontitis: a systematic review and meta-analysis. J Periodontal Res 2015; 50: 294-314
- 14 Keestra JA, Grosjean I. Coucke. et al. Non-surgical periodontal therapy with systemic antibiotics in patients with untreated aggressive periodontitis: a systematic review and meta-analysis. J Periodontal Res 2015; 50: 689-706
- 15 Zandbergen D, Slot DE, Cobb CM. et al. The clinical effect of scaling and root planing and the concomitant administration of systemic amoxicillin and metronidazole: a systematic review. J Periodontol 2013; 84: 332-351
- 16 Teughels W, Feres M, Oud V. et al. Adjunctive effect of systemic antimicrobials in periodontitis therapy. A systematic review and meta-analysis. J Clin Periodontol 2020; 47 (Suppl. 22) 257-281
- 17 Harks I, Koch R, Eickholz P. et al. Is progression of periodontitis relevantly influenced by systemic antibiotics? A clinical randomized trial. J Clin Periodontol 2015; 42: 832-842
- 18 Eickholz P, Koch R, Kocher T. et al. Clinical benefits of systemic amoxicillin/metronidazole may depend on periodontitis severity and patientsʼ age: An exploratory sub-analysis of the ABPARO trial. J Clin Periodontol 2019; 46: 491-501
- 19 Jepsen K, Jepsen S. Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis. Periodontol 2000 2016; 71: 82-112
- 20 McGowan K, McGowan T, Ivanovski S. Optimal dose and duration of amoxicillin-plus-metronidazole as an adjunct to non-surgical periodontal therapy: A systematic review and meta-analysis of randomized, placebo-controlled trials. J Clin Periodontol 2018; 45: 56-67
- 21 Pretzl B, Salzer S, Ehmke B. et al. Administration of systemic antibiotics during non-surgical periodontal therapy-a consensus report. Clin Oral Investig 2019; 23: 3073-3085
- 22 Cosgarea R, Juncar R, Heumann C. et al. Non-surgical periodontal treatment in conjunction with 3 or 7 days systemic administration of amoxicillin and metronidazole in severe chronic periodontitis patients. A placebo-controlled randomized clinical study. J Clin Periodontol 2016; 43: 767-777
- 23 Cosgarea R, Heumann C, Juncar R. et al. One year results of a randomized controlled clinical study evaluating the effects of non-surgical periodontal therapy of chronic periodontitis in conjunction with three or seven days systemic administration of amoxicillin/metronidazole. PLoS One 2017; 12: e0179592
- 24 Cosgarea R, Eick S, Jepsen S. et al. Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT. Sci Rep 2020; 10: 16322
- 25 Cosgarea R, Jepsen S, Heumann C. et al. Clinical, microbiological and immunological effects of 3- or 7-day systemic antibiotics adjunctive to subgingival instrumentation in patients with aggressive (stage III/IV grade C) periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol 2022;
- 26 Martin JSH, Monaghan TM, Wilcox MH. Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastroenterol Hepatol 2016; 13: 206-216
- 27 Sartelli M, Di Bella S, McFarland LV. et al. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World J Emerg Surg 2019; 14: 8
- 28 World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report: 2021. Im Internet (Stand: 12.08.2022): https://www.who.int/publications/i/item/97892400
- 29 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399: 629-655
- 30 Jepsen K, Falk W, Brune F. et al. Prevalence and Antibiotic Susceptibility Trends of Selected Enterobacteriaceae, Enterococci, and Candida albicans in the Subgingival Microbiota of German Periodontitis Patients: A Retrospective Surveillance Study. Antibiotics (Basel) 2022; 11: 385
- 31 Cassini A, Högberg LD, Plachouras D. et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis 2019; 19: 56-66
- 32 Jepsen K, Falk W, Brune F. et al. Prevalence and antibiotic susceptibility trends of periodontal pathogens in the subgingival microbiota of German periodontitis patients: A retrospective surveillance study. J Clin Periodontol 2021; 48: 1216-1227
- 33 Sanz M, Herrera D, Kebschull M. et al. Treatment of stage I–III periodontitis-The EFP S3 level clinical practice guideline. J Clin Periodontol 2020; 47 Suppl 22: 4-60
- 34 Dyar OJ, Huttner B, Schouten J. et al. ESGAP (ESCMID Study Group for Antimicrobial stewardshiP). What is antimicrobial stewardship?. Clin Microbiol Infect 2017; 23: 793-798
- 35 Liu Y, Duan D, Xin Y. et al. A review of the literature: antibiotic usage and its relevance to the infection in periodontal flaps. Acta Odontol Scand 2017; 75: 288-293
- 36 Hai JH, Lee C, Kapila YL. et al. Antibiotic prescribing practices in periodontal surgeries with and without bone grafting. J Periodontol 2020; 91: 508-515
- 37 Eckmann C. Perioperative Antibiotikaprophylaxe. Im Internet (Stand: 25.07.2022): https://www.bdc.de/category/wissen/qualitatpatientensicherheit/%22%3ehttps://www.bdc.de/category/wissen/qualitatpatientensicherheit/%3c/uri%3e
- 38 Powell CA, Mealey BL, Deas DE. et al. Post-surgical infections: prevalence associated with various periodontal surgical procedures. J Periodontol 2005; 76: 329-333
- 39 Mohan RR, Doraswamy DC, Hussain AM. et al. Evaluation of the role of antibiotics in preventing postoperative complication after routine periodontal surgery: A comparative clinical study. J Indian Soc Periodontol 2014; 18: 205-212
- 40 Collins JR, Ogando G, Gonzalez R. et al. Adjunctive efficacy of systemic metronidazole in the surgical treatment of periodontitis: a double-blind parallel randomized clinical trial. Clin Oral Investig 2022; 26: 4195-4207
- 41 Nibali L, Koidou VP, Nieri M. et al. Regenerative surgery versus access flap for the treatment of intra-bony periodontal defects: A systematic review and meta-analysis. J Clin Periodontol 2020; 47 Suppl 22: 320-351
- 42 Jepsen S, Gennai S, Hirschfeld J. et al. Regenerative surgical treatment of furcation defects: A systematic review and Bayesian network meta-analysis of randomized clinical trials. J Clin Periodontol 2020; 47: 352-374
- 43 Nibali L, Buti J, Barbato L. et al. Adjunctive Effect of Systemic Antibiotics in Regenerative/Reconstructive Periodontal Surgery-A Systematic Review with Meta-Analysis. Antibiotics 2022; 11: 8
- 44 Loos BG, Louwerse PHG, Van Winkelhoff AJ. et al. Use of barrier membranes and systemic antibiotics in the treatment of intraosseous defects. J Clin Periodontol 2002; 29: 910-921
- 45 Abu-Taʼa M. Adjunctive Systemic Antimicrobial Therapy vs. Asepsis in Conjunction with Guided Tissue Regeneration: A Randomized, Controlled Clinical Trial. J Contemp Dent Pract 2016; 17: 3-6
- 46 Eickholz P, Rollke L, Schacher B. et al. Enamel matrix derivative in propylene glycol alginate for treatment of infrabony defects with or without systemic doxycycline: 12- and 24-month results. J Periodontol 2014; 85: 669-675
- 47 Pietruska M, Dolinska E, Milewski R, Sculean A. Effect of systemic antibiotics on the outcomes of regenerative periodontal surgery in intrabony defects: a randomized, controlled, clinical study. Clin Oral Investig 2021; 25: 2959-2968
- 48 Goodson JM, Cugini MA, Kent RL. et al. Multicenter evaluation of tetracycline fiber therapy: I. Experimental design, methods, and baseline data. J Periodontal Res 1991; 26: 361-370
- 49 Goodson JM, Cugini MA, Kent RL. et al. Multicenter evaluation of tetracycline fiber therapy: II. Clinical response. J Periodontal Res 1991; 26: 371-379
- 50 Hanes PJ, Purvis JP. Local anti-infective therapy: pharmacological agents. A systematic review. Ann Periodontol 2003; 8: 79-98
- 51 Bonito AJ, Lux L, Lohr KN. Impact of local adjuncts to scaling and root planing in periodontal disease therapy: a systematic review. J Periodontol 2005; 76: 1227-1236
- 52 Matesanz-Perez P, Garcia-Gargallo M, Figuero E. et al. A systematic review on the effects of local antimicrobials as adjuncts to subgingival debridement, compared with subgingival debridement alone, in the treatment of chronic periodontitis. J Clin Periodontol 2013; 40: 227-241
- 53 Smiley CJ, Tracy SL, Abt E. et al. Systematic review and meta-analysis on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. J Am Dent Assoc 2015; 146: 508-524.e5
- 54 Herrera D, Retamal-Valdes B, Alonso B. et al. Acute periodontal lesions (periodontal abscesses and necrotizing periodontal diseases) and endo-periodontal lesions. J Clin Periodontol 2018; 45 (Suppl. 20) S78-S94
- 55 Papapanou PN, Sanz M, Buduneli N. et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol 2018; 89: S173-S182
- 56 Herrera D, Alonso B, de Arriba L. et al. Acute periodontal lesions. Periodontol 2000 2014; 65: 149-177